Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Phase 2 study Inquiry
View:
Post by VentureGuy24 on Jan 10, 2021 9:22am

Phase 2 study Inquiry

Are we enrolling and treating patients? Has covid wave 2 caused another delay? This company has been very silent on all fronts. I fear our trial just got extended again.
Comment by StevenBirch on Jan 10, 2021 9:52am
I think they have learned a lot since the first lockdown last spring and maybe most importantly is that there are other illnesses and medical emergencies that are a priority also. I would be very disappointed if they had to delay again for various reasons and I think that is just speculation at this point.  Case in point, they are testing a treatment/vaccine for covid and we don't hear ...more  
Comment by Rumpl3StiltSkin on Jan 10, 2021 12:49pm
I'm expecting some great news out of TLT soon, maybe this month still. Something from Dr. Coombs. Some CR data from Phase 2. If they are both good then we may see that .50c number fall pretty damn quick.
Comment by ScienceFirst on Jan 10, 2021 2:45pm
Do you realize how far Dr. Coombs's work is just from commercialization? Would that be in hopsital settings (most probably)?  If so, much more costly.  So would we find an interested dancing partner easily? You can now see how it is not obvious to quickly vaccinate a whole population for a process that takes about 1 minute.  Imagine the cost of having the same size population ...more  
Comment by CancerSlayer on Jan 12, 2021 3:36am
  Hey RSS... still happily & patiently waiting for in-vivo small animal results re: our compound's efficacy against BSL-3 SARS-CoV-2 (virus causing Covid-19)....my timeline puts results coming out by end of Q1, then off to human trials...."subject to suitable financing" per the NR.   Crossing my fingers that "suitable financing" comes in the form of a grant ...more  
Comment by Rumpl3StiltSkin on Jan 12, 2021 10:13am
Yep, And it is verifiably safe, repeatable, 'may' be able to be activated via X-Ray. Plus it is easy to store and transport. Also, not too expensive to manufacture.
Comment by tamarindo1 on Jan 10, 2021 11:23am
Going back; way back, I vaguely remember after a positive NR in Aug 2014 a member on here saying 'wow' $1 by christmas is a no brainer'. Well I guess we all must all be no brainers on here. Then there was the 2015 anticipation of an upcoming Nasdaq listing mentioned by our then CEO, plus the constant mention of  the multi-million $ market just waiting. That Cool Laser Therapy ...more  
Comment by Yajne on Jan 10, 2021 1:34pm
tamarindo1, despite your exhaustive post below, it seems you are still here. Probably for the same reason as the rest of us...it's the science, correct? If you're not still holding TLT shares, then why are you really here?
Comment by tamarindo1 on Jan 10, 2021 2:04pm
Yajne, yes I still own shares. I still have hopes that the science will win out.  I'm simply pointing out some of the negatives that have occurred, nothing to do with the science, lots to do with management Or at least my interpretation of what has happened. I can think of no other reason  as to why this company is at 0.18c. other than standard reasons of course  Big Pharma and ...more  
Comment by Yajne on Jan 10, 2021 11:56pm
tamarindo1, you have read me wrong. I totally agree that TLT management is incompetent. but what keeps me here is is the science and the strong medical team like Dr Jewett amd Dr Kulkarni that have recently been honored with awards, in addition to Dr Sherri M who will someday soon recieve a Nobel award for her amazing work. What puzzles me is why you would go out of your way to bring up the whole ...more  
Comment by skys1 on Jan 11, 2021 4:59am
Agree Yajne, For tarmarindo1 to bring up the entire negative episode in such detail indicates he must have some type of axe to grind.  Very little history, but claims to be a very long time share holder.  My guess is probably a paid basher. iggy is a good option.
Comment by tamarindo1 on Jan 11, 2021 8:57am
No skys1, not a basher paid or otherwise, but I don't bury my head in the sand.  Simply pointing out the company's past history. Because you don't want to see it doesn't mean it will go away.  My axe is for management not the science and yes I've been here for a very long time, originally under the moniker langosta1. Yes I think if you feel 'Ignore' is the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250